References
- Pittet D. Nosocomial bloodstream infections. In: Wenzel RP, ed. Prevention and Control of Nosocomial Infections. Williams & Wilkins, Baltimore. 1997: 711-769.
- Richards M, Edwards J, Culver D, Gaynes R. Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol 2000; 21 (8): 510–515.
- Souza E, Burillo A, Munoz P. Catheter-related infec-tions: diagnosis and intravascular treatment. J Chemother 2001; 13 (Spec No 1): 224-233.
- Mermel LA, Farr BM, Sherertz RJ et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001; 32: 1249–1272.
- Blot F, Nitenberg G, Chachaty E, et al. Diagnosis of catheter related bacteraemia: a prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures. Lancet 1999; 354: 1071–1077.
- Souza E. Intravascular catheter-related infections: a growing problem, the search for better solutions. Clin Microbiol Infect 2002; 8: 255.
- Raad I. Intravascular-catheter-related infections. Lancet 1998; 351: 893–898.
- Bastani B, Minton J, Islam S. Insufficient penetration of systemic Vancomycin into the PermCath lumen. Nephrol Dial Transpl 2000; 15: 1035–1037.
- Messing B, Peitra-Cohen S, Debure A, Beliah M, Bernier JJ. Antibiotic-Lock Technique: a new approach to optimal therapy for central venous catheter related sepsis in home-parenteral nutrition patients. J Parenter Enteral Nutr 1988; 12: 185–189.
- Pascual A. Pathogenesis of catheter-related infections: lessons for new designs. Clin Microbiol Infect 2002; 8: 256–264.
- Krishnasami Z, Carlton D, Bimbo L, et al. Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution. Kidney Int 2002; 61: 1136–1142.
- Boorgu R, Dubrow AJ, Levin NW, et al. Adjunctive antibiotic/ anticoagulant lock therapy in the treatment of bac-teremia associated with the use of a subcutaneously implanted hemodialysis access device. Am Soc Artificial Internal Organs J (ASAIO) 2000; 46: 767–770.
- Carratala J. The antibiotic-lock technique for therapy of “highly needed” infected catheters. Clin Microbiol Infect 2002; 8: 282–289.
- ACCP/SCCM Consensus Conference. Definition for Sepsis and Organ Failure and Guidelines for the use of innov-ative therapies in Sepsis. Chest 1992; 101: 1644–1655.
- Blot F, Brun-Buisson C. Current approaches to the diagnosis and prevention of intravascular catheter related infections Curr Opin Crit Care 1999; 5: 341–349.
- Raad I, Bodey GP. Infectious complications of indwelling vascular catheters. Clin Infect Dis 1992; 15: 197–210.
- Souza E, Burillo A, Munoz P. Catheter-related infec-tions: diagnosis and intravascular treatment. Clin Microbiol Infect 2002; 8: 265–274.
- Donlan RM, Costerton JW. Biofilms: survival mecha-nisms of clinically relevant microorganisms. Clin Microbiol Rev 2002; 15: 167–193.
- O'Gara JP, Humphreys H. Staphylococcus epider-midis biofilms: importance and implications. J Med Microbiol 2001; 50: 582–587.
- Berrington A, Gould FK. Use of antibiotic locks to treat colonized central venous catheters. J Antimicrob Chemother 2001; 48: 597–603.
- Gaillard JL, Merlino R, Pajot N, et al. Conventional and nonconventional modes of vancomycin administration to decontaminate the internal surface of catheters colonized with coagulase-negative staphylococci. J Parenter Enteral Nutr 1990; 14: 593–597.
- Domingo P, Fontanet A, Sanchèz F, Allende L, Vazquez G. Morbidity associated with long-term use of totally implantable ports in patients with AIDS. Clin Infect Dis 1999; 29: 346–351.
- Lilford R, Stevens AJ. Underpowered studies. Br J Surg 2002; 89: 129–131.
- Vercaigne LM, Sitar DS, Penner SB, Bernstein K, Wang GQ, Burczynski FJ. Antibiotic-heparin lock: in vitro antibiotic stability combined with heparin in a central venous catheter. Pharmacotherapy 2000; 20: 394–399.
- Duncan RA. Controlling use of antimicrobial agents. Infect Contr Hosp Epidemiol 1997; 18: 260–266.
- Donskey CJ, Chowdhry TK, Hecker MT et al. Effect of antibiotic therapy on the density of vancomycin-resistant ente-rococci in the stool of colonized patients. N Engl J Med 2000; 343: 1925–1932.
- Niederman MS. Impact of antibiotic resistance on clini-cal outcome and the cost of care. Crit Care Med 2001; 29: N114–N120.
- Shales DM, Gerding DN, John JFJr. et al. Society of Health Care Epidemiology of America and Infectious Diseases of America Joint Committee on the Prevention of Antimicrobial Resistance: Guidelines for the prevention of antimicrobial resistance in Hospitals. Infect Contr Hosp Epidemiol 1997; 18: 275–291.